SHG · Clinical Research Centre/Lung Cancer CDR (Pilot)
CR
Pilot environment — synthetic demographics; real de-identified pathology sample (n=62; +80 synthetic; total 142).
All patients
Patient Record · MRN SMC-255874

Patient #062

Tan Mei Ling · 55y · Female · Chinese · BMI 29.5 · ECOG 0
SVMC - Sunway Velocity · Cardiothoracic Surgery · Dr. Ng Wei Sheng
IIB (T3, N0)Disease-free
EGFR L858RTP53
Clinical storyline

Tan Mei Ling, a 55-year-old Chinese female (never, ECOG 0), presented in 2024-04 with fatigue and reduced appetite. Workup confirmed Adenocarcinoma (Stage II, EGFR L858R). The MDT recommended curative-intent surgery. Current status: Disease-free.

HPE Results
Moderately differentiated adenocarcinoma, acinar type, no LVI, no STATS, no LN involvement
Clinical Stage
IIB (T3, N0)
Pathological Stage
IIB (T3, N0, Mx)
Adenocarcinoma Subtype
Acinar
CEA (ng/mL)
8.8
Tumor (CT/PET)
3.6 cm
PET SUV
10.14
NGS Results
1. EGFR Exon 21 Mutation (L858R)
2. TP53 mutation